Format

Send to

Choose Destination
Pediatr Infect Dis J. 2019 Jun;38(6S Suppl 1):S24-S27. doi: 10.1097/INF.0000000000002333.

RSV, Antibodies and the Developing World.

Author information

1
From the School of Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC.
2
Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington.

Abstract

Respiratory syncytial virus remains a major cause of infantile respiratory illness globally. Infants in the developing world experience the highest burden of mortality and morbidity. Risk factors associated with respiratory syncytial virus infection and progression to severe disease include household crowding, preterm birth and low birth weight. Maternally-derived antibody has a role in protection of infants through transplacental antibody transfer and breast milk antibody. Promising prevention strategies that are under development include vaccination during pregnancy and monoclonal antibody administration at birth.

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center